A-type CRC showed a significantly reduced expression of two mesenchymal markers (i.e., TWIST1 and AXL Receptor Tyrosine Kinase), but also a reduction in one epithelial marker (i.e., CDH1). This evidence concerns the gene CDH1 and colorectal carcinoma.